Get the Stockscreener App
71.20
0.07%
-0.05
After Hours:
71.20
Henry Schein Inc stock is traded at $71.20, with a volume of 1.41M.
It is down -0.07% in the last 24 hours and up +13.05% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
See More
Previous Close:
$71.25
Open:
$71.13
24h Volume:
1.41M
Relative Volume:
0.91
Market Cap:
$6.21B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
29.18
EPS:
2.44
Net Cash Flow:
$421.00M
1W Performance:
-2.76%
1M Performance:
+13.05%
6M Performance:
-1.18%
1Y Performance:
-3.64%
1-Day Range:
$70.06
$71.46
1-Week Range:
$70.06
$73.63
52-Week Range:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
71.20 | 8.39B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
860.75 | 105.56B | 387.09B | 4.23B | 6.01B | 32.12 |
|
CAH
Cardinal Health Inc
|
206.97 | 48.99B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
COR
Cencora Inc
|
361.64 | 70.77B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
AHG
Akso Health Group Adr
|
1.5667 | 752.41M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-26-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-25-25 | Downgrade | Stifel | Buy → Hold |
| Jul-14-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Henry Schein at Jefferies London: Strategic Growth and Leadership Transition - Investing.com India
Transcript : Henry Schein, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 02 - MarketScreener
Key metrics from Henry Schein Inc.’s quarterly dataJuly 2025 Catalysts & Safe Entry Momentum Stock Tips - newser.com
Is Henry Schein Inc. stock ready for breakoutInsider Buying & Reliable Breakout Forecasts - newser.com
Do Wall Street Analysts Like Henry Schein Stock? - Yahoo Finance
Will Henry Schein Inc. stock attract more institutional investorsTrade Entry Report & AI Forecasted Entry/Exit Points - newser.com
Chart based exit strategy for Henry Schein Inc.Market Weekly Review & Safe Capital Growth Trade Ideas - newser.com
Applying sector rotation models to Henry Schein Inc.2025 Earnings Impact & Verified Swing Trading Watchlists - newser.com
Using flow based indicators on Henry Schein Inc.Trade Signal Summary & Capital Efficient Trading Techniques - newser.com
Can Henry Schein Inc. stock hit analyst price targets2025 Earnings Impact & Verified Swing Trading Watchlists - newser.com
What moving averages say about Henry Schein Inc.Risk Management & Community Consensus Stock Picks - newser.com
What risks investors should watch in Henry Schein Inc. stock2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Henry Schein (HSIC): Fresh Sales Guidance and Strong Earnings Bring Valuation Back Into Focus - Yahoo Finance
What recovery options are there for Henry Schein Inc.Jobs Report & Verified Momentum Stock Ideas - newser.com
What drives Henry Schein Inc stock priceInstitutional Buying Trends & Capitalize On Fast Trends - earlytimes.in
Tools to assess Henry Schein Inc.’s risk profileJuly 2025 Review & Safe Capital Investment Plans - newser.com
Is Henry Schein Inc. stock dividend yield sustainableJuly 2025 Selloffs & Weekly High Return Stock Forecasts - newser.com
Henry Schein, Inc.'s (NASDAQ:HSIC) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - 富途牛牛
Analyzing drawdowns of Henry Schein Inc. with statistical tools2025 Market Sentiment & Free Community Supported Trade Ideas - newser.com
Henry Schein Inc. stock volume spike explainedQuarterly Portfolio Review & Technical Analysis for Trade Confirmation - newser.com
Henry Schein (HSIC): Assessing Valuation After Recent 16% Share Price Climb - simplywall.st
New Two-Volume Book UNJUST GAGGLE OF GAVELS Exposes Corruption in Oklahoma Medical Laboratory Industry - GlobeNewswire Inc.
Henry Schein to Participate in Upcoming Investor Conference in December - The Globe and Mail
Has Henry Schein Inc. found a price floorMarket Performance Summary & Consistent Profit Focused Trading Strategies - newser.com
Henry Schein at Stifel 2025 Healthcare Conference: Strategic Initiatives and Growth - Investing.com Nigeria
Transcript : Henry Schein, Inc. Presents at Stifel 2025 Healthcare Conference, Nov-12-2025 11 - MarketScreener
Will Henry Schein Inc. rebound enough to break evenQuarterly Earnings Report & Real-Time Volume Analysis - newser.com
The Bull Case For Henry Schein (HSIC) Could Change Following Launch of AI-Powered Impact Panel Integration - simplywall.st
Will earnings trigger a reversal in Henry Schein Inc.Weekly Trading Summary & Daily Growth Stock Investment Tips - newser.com
Henry Schein (HSIC) Receives a Hold from UBS - The Globe and Mail
Henry Schein Inc. Stock Rises Monday, Still Underperforms Market - 富途牛牛
Can Henry Schein Inc. recover in the next quarter2025 Performance Recap & Step-by-Step Swing Trade Plans - newser.com
What candlestick patterns are forming on Henry Schein Inc.2025 Winners & Losers & High Accuracy Investment Entry Signals - newser.com
Nuance Investments Dumps $38 Million in Henry Schein (NASDAQ: HSIC) Shares: Should Investors Sell Too? - The Motley Fool
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Henry Schein Inc Stock (HSIC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DANIEL WILLIAM K | Director |
Aug 07 '25 |
Buy |
67.08 |
10,000 |
670,800 |
10,000 |
| LASKAWY PHILIP A | Director |
Mar 19 '25 |
Sale |
71.04 |
2,604 |
184,999 |
24,805 |
| Connett Bradford C | CEO, NA Distribution Group |
Mar 19 '25 |
Sale |
71.15 |
4,036 |
287,161 |
62,688 |
14.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):